PPCB
PPCB
NASDAQ · Biotechnology

Propanc Biopharma Inc

$0.19
-0.01 (-5.99%)
As of Feb 8, 2:34 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 398.2K 400.3K 406.3K
Net Income -29,112 -35,289 -31,464
EPS
Profit Margin -7.3% -8.8% -7.7%
Rev Growth +16.9% +4.6% -8.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 261.2K 296.5K 237.0K
Total Equity 1.97M 1.98M 1.80M
D/E Ratio 0.13 0.15 0.13
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -48,158 -49,842 -45,919
Free Cash Flow -34,661 -49,903 -42,011